Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma

European Journal of Endocrinology

Volumn 143, Issue 5, 2000, Pages 615-621

  Nobels, F R E ^a   De Herder, W W ^a   Van den Brink, W M ^a   Kwekkeboom, D J ^a   Hofland, L J ^a   Zuyderwijk, J ^a   De Jong, F H ^a   Lamberts, S W J ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; QUINAGOLIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; GONADOTROPIN BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; SCINTIGRAPHY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0033668887     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430615     Document Type: Article

References (35)

1. Nonsecreting pituitary tumors
2. Clinically nonfunctioning pituitary adenomas
3. Clinical review 45. Clinically nonfunctioning pituitary adenomas
4. Imaging and medical management of clinically nonfunctioning pituitary tumors
5. Extensive personal experience: Gonadotroph adenomas
6. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture
7. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas
8. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: Relation to sex and effects of TRH, GnRH and bromocriptine
9. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors
10. Regulation of prolactin secretion at the level of the lactotroph
11. Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine
12. Demonstration of specific dopamine receptors on human pituitary adenomas
13. Iodine-123-IBZM-SPECT: Studies in 15 patients with pituitary tumors
14. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand
15. 123I]-epidepride and SPECT
16. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging in clinically nonfunctioning pituitary macroadenomas and macroprolactinomas
17. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro
18. Dopaminergic regulation of α-subunit secretion and messenger ribonucleic acid levels in α-secreting pituitary tumours
19. Bromocriptine increasingly suppresses the in vitro gonadotropin and α-subunit release from pituitary adenomas during long term culture
20. Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro
21. Luteinizing hormone-secreting pituitary tumor: Biosynthetic characterization and clinical studies
22. Follicle-stimulating hormone- and α-subunit secreting pituitary tumor treated with bromocriptine
23. Dopamine, the dopamine D2 receptor and pituitary tumours
24. Dopamine agonists and pituitary tumor shrinkage
25. A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia
26. Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically nonfunctioning, gonadotroph, or α-subunit secreting pituitary adenoma
27. Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomas
28. Extradural hematomas: Measurement of size by volume summation on CT scanning
29. Measurement of tumor resection volumes from computerized images
30. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization
31. A comparison between the diagnostic value of the measurement of gonadotropins, α-subunits and chromogranin A and their response to TRH in clinically non functioning, α-subunit secreting and gonadotroph pituitary adenomas
32. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results
33. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas
34. The clinical and endocrine outcome to transsphenoidal microsurgery of nonsecreting pituitary adenomas
35. Radiotherapy for non-functioning pituitary tumours